Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose

OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS: A total of 3,450 subjects with 2-h plasma glucose concentration...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 33; no. 3; pp. 557 - 561
Main Authors Abdul-Ghani, Muhammad A, Stern, Michael P, Lyssenko, Valeriya, Tuomi, Tiinamaija, Groop, Leif, DeFronzo, Ralph A
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.03.2010
Subjects
Online AccessGet full text
ISSN0149-5992
1935-5548
1935-5548
DOI10.2337/dc09-1145

Cover

Loading…
Abstract OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS: A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS: In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS: An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.
AbstractList OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.
To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. A total of 3,450 subjects with 2-h plasma glucose concentration < 140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.
OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a normal 2-h plasma glucose concentration. RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma glucose concentration <140 mg/dl at baseline were followed up in the San Antonio Heart Study (SAHS) and the Botnia Study for 7-8 years. The incidence of type 2 diabetes at follow-up was related to the fasting, 1-h, and 2-h plasma glucose concentrations. RESULTS In subjects with 2-h plasma glucose <140 mg/dl, the incidence of type 2 diabetes increased with increasing fasting plasma glucose (FPG) and 1-h and 2-h plasma glucose concentrations. In a multivariate logistic analysis, after adjustment for all diabetes risk factors, the FPG concentration was a strong predictor of type 2 diabetes in both the SAHS and the Botnia Study (P < 0.0001). However, when the 1-h plasma glucose, but not 2-h plasma glucose, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 diabetes in both studies (NS). When subjects were matched for the level of 1-h plasma glucose concentration, the incidence of type 2 diabetes markedly increased with the increase in 1-h plasma glucose, but the increase in FPG was not associated with a significant increase in the incidence of type 2 diabetes. CONCLUSIONS An increase in postload glycemia in the normal range is associated with an increase in the incidence of type 2 diabetes. After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes.
Audience Professional
Author Stern, Michael P
Groop, Leif
Abdul-Ghani, Muhammad A
DeFronzo, Ralph A
Lyssenko, Valeriya
Tuomi, Tiinamaija
Author_xml – sequence: 1
  fullname: Abdul-Ghani, Muhammad A
– sequence: 2
  fullname: Stern, Michael P
– sequence: 3
  fullname: Lyssenko, Valeriya
– sequence: 4
  fullname: Tuomi, Tiinamaija
– sequence: 5
  fullname: Groop, Leif
– sequence: 6
  fullname: DeFronzo, Ralph A
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22509189$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20007945$$D View this record in MEDLINE/PubMed
https://lup.lub.lu.se/record/1589074$$DView record from Swedish Publication Index
oai:portal.research.lu.se:publications/3f60b1ca-54e2-4f06-83b4-e930c052f0d0$$DView record from Swedish Publication Index
BookMark eNqNk9tu1DAQhiNURA9wwQuABQLERVofk_gGqSr0IJWD1FZcWo4z2XXltRc7AVXi4XHYFmi1IBRZieJv_hmP_9kuNnzwUBSPCd6ljNV7ncGyJISLe8UWkUyUQvBmo9jChMtSSEk3i-2ULjHGnDfNg2KT5s9acrFVfH9vvV1ohw6CH6Jtx8EGj0KPDnUarJ-h46slxJm7MrCwGg0BDXNAJ97YDryBiTzPBKLordUtDJCQ9ehsbC_BDAl9tsMcfQhxykDLOfrkdFpodORGExI8LO732iV4dP3eKS4O350fHJenH49ODvZPS1MLPJSNaUltqppRwWhHONHCQCeJaEjDKhAAhnWSc1GJTouaUyGo4TWRlaDaYM52Cr3STd9gObZqGfOR45UK2qpliIN2KkICHc1cuVElUJly1uipGUmxvsItMVoJDlTxHleqYS1XIBk2WNAedzjnOP1rDjcu82qvtf9T7s1KLmstoDOQbyeXeavyWzveztUsfFW0oblpdRZ4dS0Qw5cR0qAWNhlwTnsIY1I1YxnFVZXJl_8keSV4RkkGn90BL8MYfb45RSnDTEoy5X2-gmbagbK-D7k8MymqfUpJXWEsJ6pcQ83AQz5LNndv8-9b_O4aPj9dtqVZG_Dkz_79atyN8zPw4hrQyWjXR509nX5zVGBJGpm5vRVnYkgpQq-MHX4aI1dgnSJYTTOophlU0wzmiNd3Im5E17FPV2yvg9KzmCu4OKOYMEwa3HDJ2A88zjcP
CODEN DICAD2
CitedBy_id crossref_primary_10_1016_j_diabres_2021_108683
crossref_primary_10_1016_j_mcna_2010_11_002
crossref_primary_10_1007_s12018_012_9126_x
crossref_primary_10_1016_j_diabres_2024_111856
crossref_primary_10_1111_j_1365_2265_2011_04159_x
crossref_primary_10_1038_jhg_2013_14
crossref_primary_10_4158_EP_2019_0387
crossref_primary_10_2478_v10255_012_0004_6
crossref_primary_10_1002_dmrr_1025
crossref_primary_10_2337_dc11_0827
crossref_primary_10_1007_s00108_015_3737_5
crossref_primary_10_1016_j_diabres_2013_12_049
crossref_primary_10_1016_j_jcte_2019_100195
crossref_primary_10_1530_EJE_11_0827
crossref_primary_10_1371_journal_pone_0075807
crossref_primary_10_1111_jdi_12353
crossref_primary_10_1016_j_soard_2016_12_001
crossref_primary_10_1097_MCO_0000000000000307
crossref_primary_10_1007_s00592_012_0384_3
crossref_primary_10_1038_s41430_024_01457_1
crossref_primary_10_1016_j_diabres_2011_05_035
crossref_primary_10_1016_j_diabres_2018_09_017
crossref_primary_10_2337_db11_1785
crossref_primary_10_1016_j_jacl_2019_09_012
crossref_primary_10_1016_j_metabol_2010_06_017
crossref_primary_10_1007_s00125_016_4051_z
crossref_primary_10_1016_j_diabres_2024_111589
crossref_primary_10_1016_j_diabres_2024_111941
crossref_primary_10_1016_j_jcjd_2023_05_009
crossref_primary_10_1016_S1957_2557_10_70124_3
crossref_primary_10_1111_dme_12356
crossref_primary_10_2337_dc09_2261
crossref_primary_10_1155_2014_436725
crossref_primary_10_1017_S0007114511006507
crossref_primary_10_1007_s00125_017_4453_6
crossref_primary_10_21518_2079_701X_2021_12_220_227
crossref_primary_10_1093_qjmed_hcv204
crossref_primary_10_1007_s11892_013_0422_8
crossref_primary_10_1111_cen_13443
crossref_primary_10_1111_jdi_12185
crossref_primary_10_1016_j_ejim_2010_07_008
crossref_primary_10_1530_EJE_15_1221
crossref_primary_10_1007_s12020_012_9830_9
Cites_doi 10.1111/j.1464-5491.2008.02597.x
10.1093/oxfordjournals.aje.a113956
10.1016/j.diabres.2007.05.004
10.1007/s00125-003-1169-6
10.2337/dc07-1593
10.1001/archinte.159.13.1450
10.1007/s00125-002-1009-0
10.1046/j.1464-5491.2002.00835.x
10.1007/s00125-004-1339-1
10.1001/jama.1989.03430030048032
10.2337/diab.45.11.1585
10.2337/dc08-1264
10.1007/s00125-003-1263-9
10.2337/diacare.20.7.1183
10.2337/dc06-0438
10.1007/s00125-004-1454-z
10.2337/diacare.22.3.399
10.2337/db05-1200
10.2337/diabetes.48.11.2197
10.2337/dc06-1331
10.2337/dc08-0225
10.2337/dc05-2179
ContentType Journal Article
Copyright 2015 INIST-CNRS
COPYRIGHT 2010 American Diabetes Association
Copyright American Diabetes Association Mar 2010
2010 by the American Diabetes Association. 2010
Copyright_xml – notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2010 American Diabetes Association
– notice: Copyright American Diabetes Association Mar 2010
– notice: 2010 by the American Diabetes Association. 2010
CorporateAuthor Lunds universitet
Profile areas and other strong research environments
Translational Muscle Research
Department of Clinical Sciences, Malmö
Lund University
Translationell muskelforskning
Strategiska forskningsområden (SFO)
EpiHealth: Epidemiology for Health
EXODIAB: Excellence of Diabetes Research in Sweden
Faculty of Medicine
Strategic research areas (SRA)
Medicinska fakulteten
Profilområden och andra starka forskningsmiljöer
Institutionen för kliniska vetenskaper, Malmö
CorporateAuthor_xml – name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Strategiska forskningsområden (SFO)
– name: Translationell muskelforskning
– name: EpiHealth: Epidemiology for Health
– name: Institutionen för kliniska vetenskaper, Malmö
– name: Strategic research areas (SRA)
– name: Lunds universitet
– name: Translational Muscle Research
– name: Profilområden och andra starka forskningsmiljöer
– name: Lund University
– name: EXODIAB: Excellence of Diabetes Research in Sweden
– name: Profile areas and other strong research environments
– name: Department of Clinical Sciences, Malmö
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X2
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ATCPS
AZQEC
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
M0K
M0R
M0S
M0T
M1P
M2O
M2P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
S0X
7S9
L.6
7X8
5PM
ADTPV
AOWAS
D95
DOI 10.2337/dc09-1145
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Agricultural Science Collection
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest eLibrary (NC LIVE)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection (ProQuest)
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Agricultural Science Database
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Proquest Medical Database
ProQuest Research Library
Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Lunds universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Family Health
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE


Agricultural Science Database

AGRICOLA
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
– sequence: 4
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 561
ExternalDocumentID oai_portal_research_lu_se_publications_3f60b1ca_54e2_4f06_83b4_e930c052f0d0
oai_lup_lub_lu_se_3f60b1ca_54e2_4f06_83b4_e930c052f0d0
PMC2827507
1989832201
A221760097
20007945
22509189
10_2337_dc09_1145
US201301808493
Genre Journal Article
GroupedDBID ---
-ET
..I
.55
.GJ
.XZ
08P
0R~
18M
29F
2WC
3O-
4.4
41~
53G
5GY
5RE
5RS
5VS
6PF
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAIKC
AAKAS
AAMNW
AAQOH
AAQQT
AAWTL
AAYEP
AAYJJ
ABOCM
ABPPZ
ABUWG
ACGFO
ACGOD
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AFFNX
AFKRA
AFOSN
AFRAH
AHMBA
AI.
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
ATCPS
AZQEC
BAWUL
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BTFSW
BVXVI
C1A
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FBQ
FYUFA
GNUQQ
GUQSH
GX1
H13
HCIFZ
HMCUK
HZ~
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
ITC
J5H
K9-
KQ8
L7B
M0K
M0R
M0T
M1P
M2O
M2P
M2Q
M5~
N4W
NAPCQ
O5R
O5S
O9-
OK1
OVD
P2P
PCD
PEA
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
RHI
S0X
SJFOW
SV3
TDI
TEORI
TR2
TWZ
UKHRP
VH1
VVN
W8F
WH7
WHG
WOQ
WOW
X7M
YHG
YOC
ZCG
ZGI
ZXP
~KM
AAFWJ
AAYXX
CITATION
PHGZM
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7S9
L.6
7X8
5PM
ADTPV
AOWAS
D95
ID FETCH-LOGICAL-c750t-8cb17c6732532d141a5ced91581836e5eec3d944565da5742552c4719652ac043
IEDL.DBID 7X7
ISSN 0149-5992
1935-5548
IngestDate Thu Aug 21 06:44:11 EDT 2025
Thu Jul 03 05:06:55 EDT 2025
Thu Aug 21 18:15:44 EDT 2025
Thu Jul 10 23:25:12 EDT 2025
Fri Jul 11 06:43:09 EDT 2025
Sat Jul 26 02:15:17 EDT 2025
Tue Jun 17 21:12:43 EDT 2025
Thu Jun 12 23:53:50 EDT 2025
Tue Jun 10 20:24:44 EDT 2025
Mon Jul 21 05:56:51 EDT 2025
Wed Apr 02 07:16:23 EDT 2025
Thu Apr 24 23:05:27 EDT 2025
Tue Jul 01 04:20:21 EDT 2025
Thu Apr 03 09:45:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Endocrinopathy
Type 2 diabetes
Human
Fasting
Nutrition
Metabolic diseases
Glucose
Normal
Epidemiology
Incidence
Hyperglycemia
Fast
Endocrinology
Glycemia
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c750t-8cb17c6732532d141a5ced91581836e5eec3d944565da5742552c4719652ac043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2827507
PMID 20007945
PQID 223039917
PQPubID 47715
PageCount 5
ParticipantIDs swepub_primary_oai_portal_research_lu_se_publications_3f60b1ca_54e2_4f06_83b4_e930c052f0d0
swepub_primary_oai_lup_lub_lu_se_3f60b1ca_54e2_4f06_83b4_e930c052f0d0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2827507
proquest_miscellaneous_733282066
proquest_miscellaneous_46542821
proquest_journals_223039917
gale_infotracmisc_A221760097
gale_infotracgeneralonefile_A221760097
gale_infotracacademiconefile_A221760097
pubmed_primary_20007945
pascalfrancis_primary_22509189
crossref_citationtrail_10_2337_dc09_1145
crossref_primary_10_2337_dc09_1145
fao_agris_US201301808493
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-03-01
PublicationDateYYYYMMDD 2010-03-01
PublicationDate_xml – month: 03
  year: 2010
  text: 2010-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2010
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Godsland (2022031302540301300_B18) 2004; 47
Abdul-Ghani (2022031302540301300_B23) 2008; 295
Abdul-Ghani (2022031302540301300_B12)
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (2022031302540301300_B1) 1997; 20
Gerstein (2022031302540301300_B4) 2007; 78
Abdul-Ghani (2022031302540301300_B8) 2006; 29
Abdul-Ghani (2022031302540301300_B9) 2006; 55
Meyer (2022031302540301300_B13) 2006; 29
Burke (2022031302540301300_B21) 1999; 159
Weyer (2022031302540301300_B10) 1999; 48
Wasada (2022031302540301300_B11) 2004; 47
Stern (2022031302540301300_B19) 1984; 120
Abdul-Ghani (2022031302540301300_B6) 2009; 32
Ferrannini (2022031302540301300_B14) 2003; 46
Kahn (2022031302540301300_B17) 2003; 46
Groop (2022031302540301300_B22) 1996; 45
Unwin (2022031302540301300_B3) 2002; 19
Abdul-Ghani (2022031302540301300_B7) 2008; 31
Stern (2022031302540301300_B20) 1989; 262
Abdul-Ghani (2022031302540301300_B16) 2008; 25
Gastaldelli (2022031302540301300_B24) 2004; 47
Abdul-Ghani (2022031302540301300_B5) 2007; 30
Jani (2022031302540301300_B15) 2008; 31
Shaw (2022031302540301300_B2) 1999; 22
References_xml – volume: 25
  start-page: 1289
  year: 2008
  ident: 2022031302540301300_B16
  article-title: Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2008.02597.x
– volume: 120
  start-page: 834
  year: 1984
  ident: 2022031302540301300_B19
  article-title: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a113956
– volume: 78
  start-page: 305
  year: 2007
  ident: 2022031302540301300_B4
  article-title: Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2007.05.004
– ident: 2022031302540301300_B12
  article-title: Impaired early but not late phase insulin secretion in subjects with impaired fasting glucose
  publication-title: Eur J Clin Invest
– volume: 46
  start-page: 1211
  year: 2003
  ident: 2022031302540301300_B14
  article-title: Predominant role of reduced β-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1169-6
– volume: 31
  start-page: 311
  year: 2008
  ident: 2022031302540301300_B15
  article-title: Decreased non-insulin-dependent glucose clearance contributes to the rise in FPG in the non-diabetic range
  publication-title: Diabetes Care
  doi: 10.2337/dc07-1593
– volume: 159
  start-page: 1450
  year: 1999
  ident: 2022031302540301300_B21
  article-title: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.159.13.1450
– volume: 46
  start-page: 3
  year: 2003
  ident: 2022031302540301300_B17
  article-title: The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-002-1009-0
– volume: 19
  start-page: 708
  year: 2002
  ident: 2022031302540301300_B3
  article-title: Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention
  publication-title: Diabet Med
  doi: 10.1046/j.1464-5491.2002.00835.x
– volume: 47
  start-page: 758
  year: 2004
  ident: 2022031302540301300_B11
  article-title: Who are more insulin resistant, people with IFG or people with IGT?
  publication-title: Diabetologia
  doi: 10.1007/s00125-004-1339-1
– volume: 262
  start-page: 360
  year: 1989
  ident: 2022031302540301300_B20
  article-title: Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey
  publication-title: JAMA
  doi: 10.1001/jama.1989.03430030048032
– volume: 45
  start-page: 1585
  year: 1996
  ident: 2022031302540301300_B22
  article-title: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects
  publication-title: Diabetes
  doi: 10.2337/diab.45.11.1585
– volume: 32
  start-page: 281
  year: 2009
  ident: 2022031302540301300_B6
  article-title: Fasting versus post load plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1264
– volume: 47
  start-page: 31
  year: 2004
  ident: 2022031302540301300_B24
  article-title: Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1263-9
– volume: 20
  start-page: 1183
  year: 1997
  ident: 2022031302540301300_B1
  article-title: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
  publication-title: Diabetes Care
  doi: 10.2337/diacare.20.7.1183
– volume: 29
  start-page: 1909
  year: 2006
  ident: 2022031302540301300_B13
  article-title: Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans
  publication-title: Diabetes Care
  doi: 10.2337/dc06-0438
– volume: 47
  start-page: 1157
  year: 2004
  ident: 2022031302540301300_B18
  article-title: Loss of β cell function as fasting glucose increases in the non-diabetic range
  publication-title: Diabetologia
  doi: 10.1007/s00125-004-1454-z
– volume: 22
  start-page: 399
  year: 1999
  ident: 2022031302540301300_B2
  article-title: Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.3.399
– volume: 55
  start-page: 1430
  year: 2006
  ident: 2022031302540301300_B9
  article-title: Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VEGAS)
  publication-title: Diabetes
  doi: 10.2337/db05-1200
– volume: 48
  start-page: 2197
  year: 1999
  ident: 2022031302540301300_B10
  article-title: Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/diabetes.48.11.2197
– volume: 295
  start-page: E401
  year: 2008
  ident: 2022031302540301300_B23
  article-title: The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
  publication-title: Am J Physiol
– volume: 30
  start-page: 1544
  year: 2007
  ident: 2022031302540301300_B5
  article-title: What is the best predictor for future type 2 diabetes?
  publication-title: Diabetes Care
  doi: 10.2337/dc06-1331
– volume: 31
  start-page: 1650
  year: 2008
  ident: 2022031302540301300_B7
  article-title: One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc08-0225
– volume: 29
  start-page: 1130
  year: 2006
  ident: 2022031302540301300_B8
  article-title: Contribution of β cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
  publication-title: Diabetes Care
  doi: 10.2337/dc05-2179
SSID ssj0004488
Score 2.2128894
Snippet OBJECTIVE: To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects...
OBJECTIVE To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects...
To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects with a...
OBJECTIVE - To assess the relative contribution of increased fasting and postload plasma glucose concentrations to the incidence of type 2 diabetes in subjects...
SourceID swepub
pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 557
SubjectTerms Adult
analysis
Biological and medical sciences
blood
blood glucose
Blood Glucose - analysis
Blood pressure
Clinical Medicine
complications
Dextrose
Diabetes
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - etiology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinology and Diabetes
Endocrinopathies
Endokrinologi och diabetes
epidemiology
etiology
Etiopathogenesis. Screening. Investigations. Target tissue resistance
fasting
Fasting - blood
Female
Follow-Up Studies
Glucose
Glucose Tolerance Test
heart
Humans
Hyperglycemia
Hyperglycemia - complications
Hyperglycemia - epidemiology
Incidence
Klinisk medicin
logit analysis
Male
Medical and Health Sciences
Medical sciences
Medicin och hälsovetenskap
Metabolic diseases
Middle Aged
Miscellaneous
noninsulin-dependent diabetes mellitus
Original Research
Public health. Hygiene
Public health. Hygiene-occupational medicine
Risk Factors
Statistical methods
Studies
Time Factors
Type 2 diabetes
Variables
Title Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose
URI https://www.ncbi.nlm.nih.gov/pubmed/20007945
https://www.proquest.com/docview/223039917
https://www.proquest.com/docview/46542821
https://www.proquest.com/docview/733282066
https://pubmed.ncbi.nlm.nih.gov/PMC2827507
https://lup.lub.lu.se/record/1589074
oai:portal.research.lu.se:publications/3f60b1ca-54e2-4f06-83b4-e930c052f0d0
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJiEkhPjcwkaxEAJeosV2nI8nNKaWCtRqfFRMvFiO47SV2qQs7QMSfzx3SZotoiAeEqny1bFyl_uw735HyEsTGBYKhtkNWrpYK-kmSZS4CUtiT6eWpREWCo_GwXDif7iUl01uTtmkVW51YqWo08LgHvkpmDEPjCkL365-uNg0Cg9Xmw4ae-QAkcsw9govw-uySL9qO4lBgCvjmNfAQlyI8DQ12AWAYRHTDXO0l-miVc13V7qE15TV_S12OaB_5lF20EYrCzW4T-41riU9q2XhAbll84fk9qg5PH9Efo3m-XwJFIhIte1zRYuMDnSJyc90CDHp1XTx09jlXNN1QcE5pKBA6r6jSIlRK-W0SaMp6TynoHlwK6ek3-brGR2jC7yg3J3RC_DLl5q-r3PiH5PJoP_1fOg2zRdcA07E2o1MwkIThIJLwVPmAyuNTWMmwcKLwEprjUhjHx3CVEsIsKXkBixdHEiujeeLJ2Q_L3J7RKgRNk5lxmFpsQ_TRIalgmkILLmvI2kc8mbLA2UaZHJskLFQEKEguxSyC-unpUNetKSrGo5jF9ERMFLpKahJNfnC8XCWRV7kx8Ihr5G7Cr9eeITRTRECLBRxsNQZhxAtwOIWh7zqUE5rFPBdhCcdQvg8TWe41xGkdtmgSMFXi2KHHG8lSzX6o1SttDvkeTuKM2NKXG6LTakQCA_iZeYQ-heKUAhewfU75LAW1OuHo28Y46sKOyLcEiDqeHckn88q9HGYEgQEFtavhb3zl8VmBVcClyqtElngJcxoJX3LlZ95gYpE4isbC894kmde6jnk-4556thTNYBXs2a-1Y2d7P-a_Ok_3-0xuVPngmBG4QnZX19t7DNwMddJr1IkcI_OWY8cvOuPLz7Dr4-fot9U4n0M
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe2IQESQnwvbGwW4uslWmzHSfyA0DQ2OrZOSGxi4sU4jrNW6tKydEKT-Jf4H7mr024RBfGyhzz5erFy19_d2fdByAubWJYKhtkNRoZYKxnmeZaHOctVZArHigwLhbsHSeco_ngsjxfIr2ktDKZVTjFxAtTF0OIZ-QaYsQiMKUvfjb6HODQKL1enEzS8Vuy5ix8QsdVvd9-DeF9yvrN9uNUJm6ECoQXjOA4zm7PUJqngUvCCxbBF6wrFJFgukTjpnBWFitHRKYyEwFFKbgHBVSK5sVEsgO8iuRELkWKr_mzrMqMEIp3MZ0yqUCrFfSMjDpQbhcWpAwyLpq6Yv8XSDGem4M7I1CCW0s_TmOfw_pm32epuOrGIO_fI3caVpZte9-6TBVc9IDe7zWX9Q_Kz26_6p0CBHbCmc7XosKQ7psZka9qBGPjsZHBh3Wnf0PGQgjNKAbD8nFOkxCiZctqk7dS0X1FAOjw6qumX_rhHD9DlHlAe9ugniANODf3gc_AfkaNrkctjslQNK7dMqBVOFbLksDUVA5vMskIwA4Esj00mbUDeTGWgbdMJHQdyDDRERCgujeLCem0ZkOcz0pFv_zGPaBkEqc0JwLI--szxMphlURYrEZDXKF2NaAGvsKYpeoCNYt8tvckhJEywmCYgr1qUJ77r-DzC1RYhwIFtLa-1FGm2bQBu8A0zFZCVqWbpBq9qPft3BWR9toqcMQWvcsPzWmPjPYjPWUDoXyhSIfhkPEBAnnhFvXw5-qIKP1XaUuEZAXY5b69U_d6k2zmwBAWBjW17ZW_9ZHA-gieHR9dOizKJcmaNlrHjOi6jRGcij7VTIrKR5GVURAH5OoePj3V102Cr1_AbXTk5_y_mT__5bdfJrc5hd1_v7x7srZDbPg8FsxlXydL47Nw9A_d2nK9NQIWSb9eNYr8B4lOz6Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF61RaqQEOJd09KuEK-LFe-u148DQhVtSCmJKkFE1MuyXq-TSIkT6kSoEn-Mf8dM7KS1CIhLDz55PF55xt_M7M6DkBcmMCwUDLMbtHSxVtJNkihxE5bEnk4tSyMsFG53glbX_9iTvQ3ya1kLg2mVS0xcAHU6MbhH3gAz5oExZWEjq7Iizo6a76bfXRwghQety2kapYac2ssfEL0Vb0-OQNQvOW8ef3nfcqsBA64BQzlzI5Ow0ASh4FLwlPmwXGPTmEmwYiKw0loj0thHpyfVEoJIKbkBNI8DybXxfAF8N8mtUIDVhF8p7IVXJZn-YuQlBiCujGNeNjXiQoSN1OAEAoYFVNdM4WamJyuzcGeqCxBRVs7WWOf8_pnDWet0urCOzXvkbuXW0sNSD--TDZs_INvt6uD-IfnZHubDMVBgN6zljC06yWhTF5h4TVsQD1_0R5fGjoeaziYUHFMK4FXOPEVKjJgpp1UKT0GHOQXUw22kgn4dzga0g-73iHJ3QM8gJhhr-qHMx39Eujcil8dkK5_kdodQI2ycyozD0mIf2ESGpYJpCGq5ryNpHPJmKQNlqq7oOJxjpCA6QnEpFBfWbkuHPF-RTstWIOuIdkCQSvcBolX3M8eDYRZ5kR8Lh7xG6SpEDniF0VUBBCwUe3CpQw7hYYCFNQ55VaPslx3I1xHu1QgBGkzt9n5NkVbLBhAHPzGKHbK71CxVYVehVn-aQw5Wd5EzpuPldjIvFDbhg1idOYT-hSIUgi9GBTjkSamoVy9HvzTGTxXWVHhFgB3P63fy4WDR-RxYgoLAwo5LZa89MppP4UrgUoVVIgu8hBmtpG-58jMvUJFIfGVj4RlP8sxLPYecr-FTxr2qarY1qPhNr-2i_xfzp__8tgdkG_BLfTrpnO6S22VKCiY27pGt2cXcPgNPd5bsLzCFkm83DWK_AQukuEs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Minimal+Contribution+of+Fasting+Hyperglycemia+to+the+Incidence+of+Type+2+Diabetes+in+Subjects+With+Normal+2-h+Plasma+Glucose&rft.jtitle=Diabetes+care&rft.au=Abdul-Ghani%2C+Muhammad+A&rft.au=Stern%2C+Michael+P&rft.au=Lyssenko%2C+Valeriya&rft.au=Tuomi%2C+Tiinamaija&rft.date=2010-03-01&rft.issn=0149-5992&rft.volume=33&rft.issue=3+p.557-561&rft.spage=557&rft.epage=561&rft_id=info:doi/10.2337%2Fdc09-1145&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon